When is the next reporting workshop?
Please fill in the form and your Key Account Manager will contact you.
Please click here to see prescribing information for SeHCAT™ ([75Se]tauroselcholic acid).
Please click here to see prescribing information for DaTSCAN™ ioflupane (123I).
Please click here to see prescribing information for RAPISCAN™ (regadenoson).
Adverse events should be reported.
Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to GE HealthCare at [email protected]
GE HealthCare | Privacy Policy | Update Profile | Contact Us | Unsubscribe
© 2024 GE HealthCare
GE is a trademark of General Electric Company used under trademark license
JB02360UK | 05 - 2023